JW (Cayman) Therapeutics Co. Ltd 2126.HK Stock
JW (Cayman) Therapeutics Co. Ltd Price Chart
JW (Cayman) Therapeutics Co. Ltd 2126.HK Financial and Trading Overview
| JW (Cayman) Therapeutics Co. Ltd stock price | 1.7 HKD |
| Previous Close | 3.13 HKD |
| Open | 3.14 HKD |
| Bid | 3.12 HKD x N/A |
| Ask | 3.17 HKD x N/A |
| Day's Range | 3.07 - 3.28 HKD |
| 52 Week Range | 2.7 - 9.46 HKD |
| Volume | 1.31M HKD |
| Avg. Volume | 370.63K HKD |
| Market Cap | 1.3B HKD |
| Beta (5Y Monthly) | 1.982158 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.03 HKD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.57 HKD |
2126.HK Valuation Measures
| Enterprise Value | 142.88M HKD |
| Trailing P/E | N/A |
| Forward P/E | -2.0718956 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 8.942802 |
| Price/Book (mrq) | 0.5388408 |
| Enterprise Value/Revenue | 0.981 |
| Enterprise Value/EBITDA | -0.227 |
Trading Information
JW (Cayman) Therapeutics Co. Ltd Stock Price History
| Beta (5Y Monthly) | 1.982158 |
| 52-Week Change | -60.37% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 9.46 HKD |
| 52 Week Low | 2.7 HKD |
| 50-Day Moving Average | 3.31 HKD |
| 200-Day Moving Average | 4.03 HKD |
2126.HK Share Statistics
| Avg. Volume (3 month) | 370.63K HKD |
| Avg. Daily Volume (10-Days) | 278.21K HKD |
| Shares Outstanding | 411.04M |
| Float | 303.52M |
| Short Ratio | N/A |
| % Held by Insiders | 34.09% |
| % Held by Institutions | 4.17% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -478.49% |
| Gross Margin | 40.32% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -14.75% |
| Return on Equity (ttm) | -32.89% |
Income Statement
| Revenue (ttm) | 145.7M HKD |
| Revenue Per Share (ttm) | 0.36 HKD |
| Quarterly Revenue Growth (yoy) | 158.80% |
| Gross Profit (ttm) | 58.76M HKD |
| EBITDA | -629526976 HKD |
| Net Income Avi to Common (ttm) | -846134976 HKD |
| Diluted EPS (ttm) | -2.35 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.39B HKD |
| Total Cash Per Share (mrq) | 3.47 HKD |
| Total Debt (mrq) | 279.13M HKD |
| Total Debt/Equity (mrq) | 11.86 HKD |
| Current Ratio (mrq) | 4.778 |
| Book Value Per Share (mrq) | 5.883 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -536721984 HKD |
| Levered Free Cash Flow (ttm) | -428104256 HKD |
Profile of JW (Cayman) Therapeutics Co. Ltd
| Country | Hong Kong |
| State | N/A |
| City | Shanghai |
| Address | Building B |
| ZIP | N/A |
| Phone | 86 21 5078 3699 |
| Website | https://www.jwtherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 528 |
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People's Republic of China. It offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of a range of hematological cancers. The company's pipeline products include JWCAR129, an autologous CAR-T therapy for the treatment of multiple myeloma; JWATM204, a TCR T-cell therapy candidate for the treatment of HCC; and JWATM203, an autologous T-cell receptor mimic T-cell therapy targeting alpha-fetoprotein for the treatment of hepatocellular carcinoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, China.
Q&A For JW (Cayman) Therapeutics Co. Ltd Stock
What is a current 2126.HK stock price?
JW (Cayman) Therapeutics Co. Ltd 2126.HK stock price today per share is 1.7 HKD.
How to purchase JW (Cayman) Therapeutics Co. Ltd stock?
You can buy 2126.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for JW (Cayman) Therapeutics Co. Ltd?
The stock symbol or ticker of JW (Cayman) Therapeutics Co. Ltd is 2126.HK.
Which industry does the JW (Cayman) Therapeutics Co. Ltd company belong to?
The JW (Cayman) Therapeutics Co. Ltd industry is Biotechnology.
How many shares does JW (Cayman) Therapeutics Co. Ltd have in circulation?
The max supply of JW (Cayman) Therapeutics Co. Ltd shares is 414.36M.
What is JW (Cayman) Therapeutics Co. Ltd Price to Earnings Ratio (PE Ratio)?
JW (Cayman) Therapeutics Co. Ltd PE Ratio is now.
What was JW (Cayman) Therapeutics Co. Ltd earnings per share over the trailing 12 months (TTM)?
JW (Cayman) Therapeutics Co. Ltd EPS is -2.03 HKD over the trailing 12 months.
Which sector does the JW (Cayman) Therapeutics Co. Ltd company belong to?
The JW (Cayman) Therapeutics Co. Ltd sector is Healthcare.
JW (Cayman) Therapeutics Co. Ltd 2126.HK included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Nasdaq EM Plus Korea Small Cap NQEMKRSCGBP | 1476.35 GBP 1888.16 USD |
<0.01
|
— — | 1476.35 GBP 1888.16 USD | 1476.35 GBP 1888.16 USD | — - | — — |
- {{ link.label }} {{link}}